Study: SPECT sheds light on liver function, may aid cancer treatment

02/9/2013 | MedicalXpress.com

SPECT imaging with 99mTc-labeled iminodiacetic acid before and during radiation therapy to monitor hepatic function in patients with unresectable liver cancer provides data that could allow for more personalized treatment plans, according to a study presented at an imaging and radiation therapy conference. "The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing," said lead researcher Hesheng Wang of the University of Michigan.

View Full Article in:

MedicalXpress.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA